Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Direct oral anticoagulant does not appear to offer protection against severe COVID-19

Direct oral anticoagulant does not appear to offer protection against severe COVID-19

Women face greater risk for heart failure and heart attack death than men, study finds

Women face greater risk for heart failure and heart attack death than men, study finds

New data highlights the growing impact of key risk factor for stroke in Australia

New data highlights the growing impact of key risk factor for stroke in Australia

Thromboembolism in COVID-19 patients associated with higher risk of mortality

Thromboembolism in COVID-19 patients associated with higher risk of mortality

Updated guideline on hypertrophic cardiomyopathy encourages shared decision-making

Updated guideline on hypertrophic cardiomyopathy encourages shared decision-making

ECG abnormalities can predict COVID-19 mortality

ECG abnormalities can predict COVID-19 mortality

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Vitamin D and omega-3 fatty acids do not prevent atrial fibrillation, shows study

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

Additional monitoring after cardiac surgery may be needed for patients at risk of atrial fibrillation

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

Fish oil and vitamin D supplements do not decrease nor increase the risk of atrial fibrillation

New medication may reduce risk for heart failure-related events in people with chronic heart failure

New medication may reduce risk for heart failure-related events in people with chronic heart failure

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Intravenous iron replacement reduces risk of recurrent hospitalization in patients with heart failure

Anticoagulant drug linked to greater risk of knee and hip replacements in patients with osteoarthritis

Anticoagulant drug linked to greater risk of knee and hip replacements in patients with osteoarthritis

New machine learning-based approach helps detect atrial fibrillation drivers

New machine learning-based approach helps detect atrial fibrillation drivers

Elevated birth weight is linked with atrial fibrillation later in life, shows study

Elevated birth weight is linked with atrial fibrillation later in life, shows study

Study: 5 to 10% of surgically induced weight loss linked with cardiovascular benefits

Study: 5 to 10% of surgically induced weight loss linked with cardiovascular benefits

Pollution exposure associated with stroke risk in people with atrial fibrillation

Pollution exposure associated with stroke risk in people with atrial fibrillation

Novel discovery could lead to stem cell-based treatment for heart failure

Novel discovery could lead to stem cell-based treatment for heart failure

Educational mailing for atrial fibrillation patients fails to increase uptake of stroke prevention drugs

Educational mailing for atrial fibrillation patients fails to increase uptake of stroke prevention drugs

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.